This compound is primarily utilized in research settings, particularly in the study of neurodegenerative diseases and psychiatric disorders. It acts as a potential inhibitor of monoamine oxidase (MAO) enzymes, which are involved in the breakdown of neurotransmitters like serotonin, dopamine, and norepinephrine. By inhibiting these enzymes, it may help in understanding the role of neurotransmitter regulation in conditions such as depression, Parkinson's disease, and anxiety disorders. Additionally, it is explored for its neuroprotective properties, which could contribute to the development of therapeutic agents aimed at slowing the progression of neurodegenerative diseases. Its structural properties also make it a candidate for further investigation in medicinal chemistry for designing novel drug compounds.